Chris Klee is Chief Financial Officer for Novartis US. He is a member of the US Country Leadership Team.
Most recently, Chris served in a dual capacity as Chief Operating Officer for the Novartis Institutes for BioMedical Research and Country Chief Financial Officer for Novartis US. He joined Novartis in 1993 as a Business Planning Analyst and has held a number of increasingly senior positions in the Pharma division.
Chris graduated from the Business School of The University of St. Gallen, Switzerland, with a degree in Finance and Economics.